Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic model.
about
From target selection to the minimum acceptable biological effect level for human study: use of mechanism-based PK/PD modeling to design safe and efficacious biologics.Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.Time-integrated activity coefficient estimation for radionuclide therapy using PET and a pharmacokinetic model: A simulation study on the effect of sampling schedule and noise.Application of PBPK modelling in drug discovery and development at Pfizer.The role of patient-based treatment planning in peptide receptor radionuclide therapy.Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modeling.Optimal preloading in radioimmunotherapy with anti-cD45 antibody.
P2860
Q34901024-00E575A0-8B7A-4E4C-BBDB-46AF0689B770Q38605894-AD018A69-42CD-4165-8F5D-19032B0B1503Q39430065-EE599F85-5625-4BD6-8F2A-F86769806D0EQ39692575-79971798-24A3-4628-AE52-4A9F4C9C3715Q40311407-7229FDA8-2F3D-4B09-8FE0-4AE30B6CC06FQ41945014-1EEF3E29-C4D4-44AB-917B-FFBD589AAD7EQ44286280-A59FD77D-C3F6-43FC-BD9A-799DE0C7F134
P2860
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic model.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@en
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@nl
type
label
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@en
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@nl
prefLabel
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@en
Improving anti-CD45 antibody r ...... y based pharmacokinetic model.
@nl
P2093
P1476
Improving anti-CD45 antibody r ...... ly based pharmacokinetic model
@en
P2093
Donald Bunjes
Peter Kletting
Sven N Reske
P304
P356
10.2967/JNUMED.108.054189
P407
P577
2009-01-21T00:00:00Z